Identification of MiRNA Signature for Predicting the Prognostic Biomarker of Squamous Cell Lung Carcinoma

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2022 Mar 15

PMID 35290415

Authors

Huanqing Liu

Tingting Li

Chunsheng Dong

Jun Lyu

Affiliations

Soon will be listed here.

Abstract

As explorations deepen, the role of microRNAs (miRNAs) in lung squamous cell carcinoma (LUSC), from its emergence to metastasis and prognosis, has elicited extensive concern. LUSC-related miRNA and mRNA samples were acquired from The Cancer Genome Atlas (TCGA) database. The data were initially screened and pretreated, and the R platform and series analytical tools were used to identify the specific and sensitive biomarkers. Seven miRNAs and 15 hub genes were found to be closely related to the overall survival of patients with LUSC. Determination of the expression of these miRNAs can help improve the overall survival of LUSC patients. The 15 hub genes correlated with overall survival (OS). The new miRNA markers were identified to predict the prognosis of LUSC. The findings of this study offer novel views on the evolution of precise cancer treatment approaches with high reliability.

Citing Articles

[Predictive Value of A miRNA Signature for Distant Metastasis in Lung Cancer].

Cong J, Wang A, Wang Y, Li X, Pi J, Liu K Zhongguo Fei Ai Za Zhi. 2025; 27(12):919-930.

PMID: 39962847 PMC: 11839496. DOI: 10.3779/j.issn.1009-3419.2024.102.43.

Transcriptome profiling and metabolic pathway analysis towards reliable biomarker discovery in early-stage lung cancer.

Thirunavukkarasu M, Ramesh P, Karuppasamy R, Veerappapillai S J Appl Genet. 2024; 66(1):115-126.

PMID: 38443694 DOI: 10.1007/s13353-024-00847-2.

Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index.

Wu R, Ma R, Duan X, Zhang J, Li K, Yu L Front Immunol. 2023; 14:1236444.

PMID: 37841237 PMC: 10570622. DOI: 10.3389/fimmu.2023.1236444.

MicroRNA-375 restrains the progression of lung squamous cell carcinoma by modulating the ERK pathway via UBE3A-mediated DUSP1 degradation.

Gan J, Zhang Y, Liu S, Mu G, Zhao J, Jiang W Cell Death Discov. 2023; 9(1):199.

PMID: 37385985 PMC: 10310764. DOI: 10.1038/s41420-023-01499-7.

Panel of miR-150 and linc00673, regulators of CCR6/CCL20 may serve as non-invasive diagnostic marker of non-small cell lung cancer.

Baran K, Kordiak J, Jablonski S, Brzezianska-Lasota E Sci Rep. 2023; 13(1):9642.

PMID: 37316552 PMC: 10267173. DOI: 10.1038/s41598-023-36485-7.

References

Queiroz A, Zhang B, Comstock D, Hao Y, Eriksson M, Hydbring P . miR-126-5p targets Malate Dehydrogenase 1 in non-small cell lung carcinomas. Biochem Biophys Res Commun. 2018; 499(2):314-320. DOI: 10.1016/j.bbrc.2018.03.154. View

Lee Y, Dutta A . MicroRNAs in cancer. Annu Rev Pathol. 2008; 4:199-227. PMC: 2769253. DOI: 10.1146/annurev.pathol.4.110807.092222. View

Zhou J, Zhang S, Li Z, Chen Z, Xu Y, Ye W . Yap-Hippo promotes A549 lung cancer cell death via modulating MIEF1-related mitochondrial stress and activating JNK pathway. Biomed Pharmacother. 2019; 113:108754. DOI: 10.1016/j.biopha.2019.108754. View

Harrison E, Porrello A, Bowman B, Belanger A, Yacovone G, Azam S . A Circle RNA Regulatory Axis Promotes Lung Squamous Metastasis via CDR1-Mediated Regulation of Golgi Trafficking. Cancer Res. 2020; 80(22):4972-4985. PMC: 7669576. DOI: 10.1158/0008-5472.CAN-20-1162. View

Zhang Y, Guo X, Li Z, Li B, Li Z, Li R . A systematic investigation based on microRNA-mediated gene regulatory network reveals that dysregulation of microRNA-19a/Cyclin D1 axis confers an oncogenic potential and a worse prognosis in human hepatocellular carcinoma. RNA Biol. 2015; 12(6):643-57. PMC: 4615594. DOI: 10.1080/15476286.2015.1022702. View

Cao D, Wang Y, Li D, Wang L . Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma. Crit Rev Eukaryot Gene Expr. 2020; 29(6):539-549. DOI: 10.1615/CritRevEukaryotGeneExpr.2019028740. View

Srivastava S, Gopal-Srivastava R . Biomarkers in cancer screening: a public health perspective. J Nutr. 2002; 132(8 Suppl):2471S-2475S. DOI: 10.1093/jn/132.8.2471S. View

Borchert G, Lanier W, Davidson B . RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol. 2006; 13(12):1097-101. DOI: 10.1038/nsmb1167. View

Kim B, Hong S, Kim A, Choi S, Yoon S . Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma. J Surg Oncol. 2012; 107(5):505-10. DOI: 10.1002/jso.23271. View

10.

Yoneshima Y, Kato K, Minami H, Ikeda M, Watanabe H, Yoshimoto G . HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitors. Cancer Sci. 2020; 111(9):3395-3396. PMC: 7469807. DOI: 10.1111/cas.14536. View

11.

Li J, Yu M, Liu Z, Liu B . Clinical significance of serum miR-25 in non-small-cell lung cancer. Br J Biomed Sci. 2019; 76(3):111-116. DOI: 10.1080/09674845.2019.1592915. View

12.

Xu C, Ping Y, Li X, Zhao H, Wang L, Fan H . Prioritizing candidate disease miRNAs by integrating phenotype associations of multiple diseases with matched miRNA and mRNA expression profiles. Mol Biosyst. 2014; 10(11):2800-9. DOI: 10.1039/c4mb00353e. View

13.

Yang J, Li Y, Liu Q, Li L, Feng A, Wang T . Brief introduction of medical database and data mining technology in big data era. J Evid Based Med. 2020; 13(1):57-69. PMC: 7065247. DOI: 10.1111/jebm.12373. View

14.

Vosa U, Vooder T, Kolde R, Vilo J, Metspalu A, Annilo T . Meta-analysis of microRNA expression in lung cancer. Int J Cancer. 2012; 132(12):2884-93. DOI: 10.1002/ijc.27981. View

15.

Hamilton M, Rajapakshe K, Hartig S, Reva B, McLellan M, Kandoth C . Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif. Nat Commun. 2013; 4:2730. PMC: 3868236. DOI: 10.1038/ncomms3730. View

16.

Calin G, Sevignani C, Dumitru C, Hyslop T, Noch E, Yendamuri S . Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004; 101(9):2999-3004. PMC: 365734. DOI: 10.1073/pnas.0307323101. View

17.

Zhang L, Liu T, Chen H, Zhao Q, Liu H . Predicting lncRNA-miRNA interactions based on interactome network and graphlet interaction. Genomics. 2021; 113(3):874-880. DOI: 10.1016/j.ygeno.2021.02.002. View

18.

Chen Y, Guo Y, Shi K, Huang H, Huang S, Xu W . Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data. Respir Res. 2019; 20(1):48. PMC: 6399847. DOI: 10.1186/s12931-019-0994-1. View

19.

Yu L, Chen J, Liu Y, Zhang Z, Duan S . MicroRNA-937 inhibits cell proliferation and metastasis in gastric cancer cells by downregulating FOXL2. Cancer Biomark. 2017; 21(1):105-116. DOI: 10.3233/CBM-170310. View

20.

Cappellesso R, Nicole L, Caroccia B, Guzzardo V, Ventura L, Fassan M . Young investigator challenge: MicroRNA-21/MicroRNA-126 profiling as a novel tool for the diagnosis of malignant mesothelioma in pleural effusion cytology. Cancer Cytopathol. 2016; 124(1):28-37. DOI: 10.1002/cncy.21646. View